Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.24.69 (
botulinum neurotoxin
)
1,901
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The catalytic activity of the highly potent botulinum neurotoxins are confined to their N-terminal light chains ( approximately 50kDa). A full-length light chain for the type E neurotoxin with a C-terminal 6x His-tag,
BoNT
/E-LC, has been cloned in a pET-9c vector and over-expressed in BL21 (DE3) cells.
BoNT
/E-LC was purified to homogeneity by affinity chromatography on Ni-
NTA
agarose followed by exclusion chromatography using a Superdex-75 sizing column. The purified protein has very good solubility and can be stored stably at -20 degrees C; however, it seems to undergo auto-proteolysis when stored at temperature #10878;4-10 degrees C.
BoNT
/E-LC is active on its natural substrate, the synaptosomal associated 25kDa protein, SNAP-25, indicating that it retains a native-like conformation and therefore can be considered as a useful tool in studying the structure/function of the catalytic light chain. Recombinant
BoNT
/E-LC has been crystallized under five different conditions and at various pHs. Crystals diffract to better than 2.1A.
...
PMID:Cloning, high level expression, purification, and crystallization of the full length Clostridium botulinum neurotoxin type E light chain. 1476 4